Recent News

• 04.02.2025 - Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share
• 04.02.2025 - Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share
• 04.02.2025 - Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share
• 03.12.2025 - Allakos Provides Business Update and Reports Fourth Quarter 2024 Financial Results
• 03.12.2025 - Allakos Provides Business Update and Reports Fourth Quarter 2024 Financial Results
• 03.12.2025 - Allakos Provides Business Update and Reports Fourth Quarter 2024 Financial Results

Recent Filings

• 04.02.2025 - EX-99.1 EX-99.1
• 04.02.2025 - 8-K Current report
• 04.02.2025 - SC14D9C Written communication relating to third party tender offer
• 03.13.2025 - 8-K Current report
• 03.12.2025 - 8-K Current report
• 03.12.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.12.2025 - EX-99.1 EX-99.1
• 03.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.07.2025 - 4 Statement of changes in beneficial ownership of securities